2-[3-nitro-4-(pyrrolidin-1-yl)benzenesulfonamido]acetic acid, 98%, 250mg

5-BROMO-7-METHOXY-1H-INDOLE, 95.0%, 1g

(3-Bromo-5-fluorophenyl)boronic acid, 98.0%, 10g

2-(2-(1H-Indol-3-yl)acetamido)pentanedioic acid, 97%, 10g

tert-Butyl ((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)carbamate, 96%, 1g

(S)-Morpholine-3-carboxylic acid hydrochloride, 95.0%, 1g

Diethyl (2-oxo-2-phenylethyl)phosphonate, 95.0%, 1g

3-Benzyloxy-4-fluorophenol, 95%, 1g

(2-Ethoxypyrimidin-5-yl)boronic acid, 95.0%, 5g

Columna HPLC NUCLEODUR® C18 Gravedad 3 µm, 250 mm, 4 mm, 1 Pieza(s)

4-chloro-2,7-dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine, 95.0%, 1g

4-Ethyl-2-nitroaniline, 97%, 1g

9-Bromoacridine, 97%, 1g